University of North Carolina at Chapel Hill

Publications

Leveraging public health infrastructures to support sexual health for women living in the Southern United States

University of North Carolina at Chapel Hill Bristol Myers Squibb Cleveland Clinic

Factors Predicting Loss of Remission in Crohn's Disease Patients in Endoscopic Remission in the Real World Results From TARGET-IBD

Harvard T.H. Chan School of Public Health University of North Carolina at Chapel Hill

Use of tenofovir-based PrEP among pregnant women in South Africa

University of Alabama at Birmingham University of North Carolina at Chapel Hill

Comparing PCSK9 Monoclonal Antibody Treatment Strategies Following Myocardial Infarction Using Negative Control Outcomes: A Target Trial Emulation Study

University of Chicago University of North Carolina at Chapel Hill University of Wisconsin Bristol Myers Squibb Cleveland Clinic Mount Sinai

Outcomes of early vs. delayed advanced therapy among patients with moderate ulcerative colitis in the United States: TARGET-IBD

Total Publications

Abstract/Manuscript

Oral Presentation

Poster Presentation

2025 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Leveraging public health infrastructures to support sexual health for women living in the Southern United States

2024 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Factors Predicting Loss of Remission in Crohn's Disease Patients in Endoscopic Remission in the Real World Results From TARGET-IBD

2024 · Abstract/Manuscript · Harvard T.H. Chan School of Public Health

Use of tenofovir-based PrEP among pregnant women in South Africa

2024 · Abstract/Manuscript · University of Alabama at Birmingham

Comparing PCSK9 Monoclonal Antibody Treatment Strategies Following Myocardial Infarction Using Negative Control Outcomes: A Target Trial Emulation Study

2023 · Poster Presentation · University of Chicago · Gastroenterology

Outcomes of early vs. delayed advanced therapy among patients with moderate ulcerative colitis in the United States: TARGET-IBD

2023 · Poster Presentation · University of North Carolina at Chapel Hill · Gastroenterology

Treatment Journey among patients with moderate ulcerative colitis in the United States: TARGET-IBD

2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel Disease

2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Evaluation of a Natural Language Processing Model to Identify and Characterize Patients in the United States With High-Risk Non–Muscle-Invasive Bladder Cancer

2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial Emulation

2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill

When Emulating a Trial, Do as the Trialists Do: Missteps in Estimating Relative Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Booster Dose

2023 · Abstract/Manuscript · Harvard T.H. Chan School of Public Health

Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women

2023 · Abstract/Manuscript · Harvard T.H. Chan School of Public Health

High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study

2023 · Oral Presentation · Harvard T.H. Chan School of Public Health · Methods/Pharmacoepi

HIV risk perception and PrEP adherence among South African women planning for pregnancy and participating in STI screening

2022 · Poster Presentation · University of Chicago · Gastroenterology

The Impact of Early vs. Late Biologic Initiation Among Real World Patients with Crohn's Disease in TARGET IBD

2022 · Abstract/Manuscript · Atrium Health

Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD

2022 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Postpartum Medicaid enrollment and churn in North Carolina

2021 · Poster Presentation · University of North Carolina at Chapel Hill · Gastroenterology

Histological Inflammation Predicts Loss of Remission Among Crohn's Patients with Endoscopic Remission: A US Cohort Analysis

2021 · Poster Presentation · University of North Carolina at Chapel Hill · Gastroenterology

Immunomodulators are Commonly Used as Concomitant Therapy with Vedolizumab or Ustekinumab: TARGET-IBD Real World Cohort

2021 · Poster Presentation · AbbVie Inc. · Gastroenterology

Biologic-naïve Patients with Crohn's Disease are More Likely to Achieve Mucosal Healing than Biologic-experienced Patients: TARGET-IBD Real World Cohort

2021 · Abstract/Manuscript · Atrium Health

Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease

2021 · Abstract/Manuscript · University of Chicago

Methodology and initial results from a real-world observational cohort of patients with inflammatory bowel disease: TARGET-IBD

2021 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Medicaid Coverage Disruptions Among Children Enrolled in North Carolina Medicaid From 2016 to 2018

2021 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Factors Associated with Readmission in the US Following Hospitalization with COVID-19

2021 · Oral Presentation · University of Alabama at Birmingham · Methods/Pharmacoepi

Lipids testing trends before and after hospitalization for myocardial infarction among adults in the United States, 2008-2019

2020 · Poster Presentation · Atrium Health · Gastroenterology

Factors Associated with Biologic Discontinuation in Patients with Inflammatory Bowel Disease in TARGET-IBD

2020 · Abstract/Manuscript · University of Alabama at Birmingham

Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines

2020 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Patient Characteristics and Outcomes of 11,721 Patients with COVID19 Hospitalized Across the United States

2020 · Poster Presentation · Atrium Health · Gastroenterology

Oral Mesalamine Use in Crohn's Disease After Implementation of the American College of Gastroenterology Guidelines: A TARGET-IBD Cohort Study (ECCO)

2020 · Poster Presentation · Atrium Health · Gastroenterology

Medication Use and Comorbidities Among Elderly as Compared to Younger Patients with Inflammatory Bowel Disease in the TARGET-IBD Cohort (ACG)

2019 · Poster Presentation · Atrium Health · Gastroenterology

Oral Mesalamine Use in Crohn's Disease After Implementation of the American College of Gastroenterology Guidelines: A TARGET-IBD Cohort Study (ACG)

2019 · Oral Presentation · University of Alabama at Birmingham · Methods/Pharmacoepi

Lipid testing trends in the US before and after the release of the 2013 ACC/AHA cholesterol guidelines

2018 · Poster Presentation · Atrium Health · Gastroenterology

Development of a Novel Longitudinal Observational Cohort of Adult and Pediatric Patients with Inflammatory Bowel Disease: TARGET-IBD

2018 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States

2018 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US

2017 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi

University of North Carolina at Chapel Hill — Publications

Publications

Leveraging public health infrastructures to support sexual health for women living in the Southern United States

Factors Predicting Loss of Remission in Crohn's Disease Patients in Endoscopic Remission in the Real World Results From TARGET-IBD

Use of tenofovir-based PrEP among pregnant women in South Africa

Comparing PCSK9 Monoclonal Antibody Treatment Strategies Following Myocardial Infarction Using Negative Control Outcomes: A Target Trial Emulation Study

Outcomes of early vs. delayed advanced therapy among patients with moderate ulcerative colitis in the United States: TARGET-IBD

Leveraging public health infrastructures to support sexual health for women living in the Southern United States

Factors Predicting Loss of Remission in Crohn's Disease Patients in Endoscopic Remission in the Real World Results From TARGET-IBD

Use of tenofovir-based PrEP among pregnant women in South Africa

Comparing PCSK9 Monoclonal Antibody Treatment Strategies Following Myocardial Infarction Using Negative Control Outcomes: A Target Trial Emulation Study

Outcomes of early vs. delayed advanced therapy among patients with moderate ulcerative colitis in the United States: TARGET-IBD

Treatment Journey among patients with moderate ulcerative colitis in the United States: TARGET-IBD

Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel Disease

Evaluation of a Natural Language Processing Model to Identify and Characterize Patients in the United States With High-Risk Non–Muscle-Invasive Bladder Cancer

Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial Emulation

When Emulating a Trial, Do as the Trialists Do: Missteps in Estimating Relative Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Booster Dose

Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women

High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study

HIV risk perception and PrEP adherence among South African women planning for pregnancy and participating in STI screening

The Impact of Early vs. Late Biologic Initiation Among Real World Patients with Crohn's Disease in TARGET IBD

Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD

Postpartum Medicaid enrollment and churn in North Carolina

Histological Inflammation Predicts Loss of Remission Among Crohn's Patients with Endoscopic Remission: A US Cohort Analysis

Immunomodulators are Commonly Used as Concomitant Therapy with Vedolizumab or Ustekinumab: TARGET-IBD Real World Cohort

Biologic-naïve Patients with Crohn's Disease are More Likely to Achieve Mucosal Healing than Biologic-experienced Patients: TARGET-IBD Real World Cohort

Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease

Methodology and initial results from a real-world observational cohort of patients with inflammatory bowel disease: TARGET-IBD

Medicaid Coverage Disruptions Among Children Enrolled in North Carolina Medicaid From 2016 to 2018

Factors Associated with Readmission in the US Following Hospitalization with COVID-19

Lipids testing trends before and after hospitalization for myocardial infarction among adults in the United States, 2008-2019

Factors Associated with Biologic Discontinuation in Patients with Inflammatory Bowel Disease in TARGET-IBD

Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines

Patient Characteristics and Outcomes of 11,721 Patients with COVID19 Hospitalized Across the United States

Oral Mesalamine Use in Crohn's Disease After Implementation of the American College of Gastroenterology Guidelines: A TARGET-IBD Cohort Study (ECCO)

Medication Use and Comorbidities Among Elderly as Compared to Younger Patients with Inflammatory Bowel Disease in the TARGET-IBD Cohort (ACG)

Oral Mesalamine Use in Crohn's Disease After Implementation of the American College of Gastroenterology Guidelines: A TARGET-IBD Cohort Study (ACG)

Lipid testing trends in the US before and after the release of the 2013 ACC/AHA cholesterol guidelines

Development of a Novel Longitudinal Observational Cohort of Adult and Pediatric Patients with Inflammatory Bowel Disease: TARGET-IBD

Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States

Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US

Patterns and Predictors of Initiation of Intravenous Bisphosphonates Among Patients with Multiple Myeloma in the United States